The latest monthly cannabis report from Health Canada questions the business model of Aurora Cannabis (ACB). The Canadian cannabis leader has constantly promoted …
When a cannabis company makes an acquisition in Canada a few quarters following the CEO claiming the market is too expensive, investors should …
Canopy Growth (CGC) remains under pressure as investors flee risky and speculative holdings, uncertainty continues to surround the cannabis sector, and the company …
With the negative sentiment surrounding the broader market and some negative news in the cannabis industry putting downward pressure on the pot market, …
No matter the positive steps taken by the US cannabis multi-state operators (MSOs), the market has completely shunned the stocks. A prime example …
A key to investing is understanding the market impact of analyst calls whether bullish or bearish. In the case of Canopy Growth (CGC), …
As U.S.
The U.S.
Extraction cannabis company MediPharm Labs (MEDIF) has been accelerating its upward growth trajectory at the right time, as Canada is poised to give …
A lot of the Canadian cannabis LPs shunned the U.S.
